medigraphic.com
SPANISH

Revista Cubana de Salud Pública

ISSN 1561-3127 (Electronic)
ISSN 0864-3466 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 2

<< Back Next >>

Revista Cubana de Salud Pública 2014; 40 (2)

Environmental impact of drugs and their regulation in Brazil

Silva GF, Bonora VFGL
Full text How to cite this article

Language: Spanish
References: 10
Page: 268-273
PDF size: 60.04 Kb.


Key words:

drug disposal, solid waste, reverse logistics, environmental legislation.

ABSTRACT

This paper presented an analysis of the evolution of the standardized treatment to dispose of non-used or expired household medicines in Brazil, identifying the changes caused by the National Solid Waste policy and the current state of implementing reverse logistics in this segment. The main aspects related to the environmental impact and toxicological potential of residues of pharmaceuticals in the environment were highlighted. In this regard, the preparation of a sectoral agreement is under way in Brazil, which is aimed at setting the terms and obligations of all the involved parties in the supply chain regarding reverse logistics in the context of drugs and defining measures and processes that provide environmentally-friendly treatment of these wastes. The implementation of the reverse logistic in the field of medications in Brazil will raise awareness of consumers about the rational use of drugs, their timely elimination and the lower effect on the environment.


REFERENCES

  1. Brandão A. Logística Reversa: Brasil busca solução para descarte inadequado de medicamentos. Pharmacia Bras. 2013;(87):7-11.

  2. Martinho MG, Santos JM. Disposal of residential pharmaceutical waste. An initial survey on attitudes, behaviors and risk perception in Portugal. International Conference on Environmental Pollution and Public Health, 5th International Conference on Bioinformatics and Biomedical Engineering. Wuhan, China: EPPH, ICBBE; 2011.

  3. Fent K, Weston AA, Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol. 2006;76(2):122-59.

  4. Carvalho EV, Ferreira E, Mucini L, Santos C. Aspectos legais e toxicológicos do descarte de medicamentos. Rev Bras Toxicol. 2009;22(1/2):1-8.

  5. Bila DM, Dezotti M. Fármacos no meio ambiente. Quim Nova. 2003;26:523-30.

  6. Bound JP, Kitsou K, Voulvoulis N. Household disposal of pharmaceuticals and perception of risk. Environ Toxicol Pharmacol. 2006;21(3):301-7 .

  7. Pomati F, Castiglioni S, Zuccato E, Fanelli R, Vigetti D, Rossetti C, et al. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ Sci Technol. 2006;(40):24427.

  8. Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci. 2008;(102):129-37.

  9. OECD. Extended producer responsability: a guidance manual for governments. Paris: OCDE; 2001.

  10. Agência Nacional de Vigilância Sanitária. Descarte de Medicamentos. Responsabilidade Compartilhada. Brasília-DF: Agência Nacional; 2013 [citado 22 Sep 2013]. Disponível Em: http://189.28.128.179:8080/descartemedicamentos /gtt/oque- e-o-gtt-de-medicamentos




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Cubana de Salud Pública. 2014;40